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Objectives. To examine the epidemiology of infectious disease (ID) hospitalisations among Alaska Native
(AN) people.
Methods. Hospitalisations with a first-listed ID diagnosis for American Indians and ANs residing in Alaska
during 20012009 were selected from the Indian Health Service direct and contract health service inpatient
data. ID hospitalisations to describe the general US population were selected from the Nationwide Inpatient
Sample. Annual and average annual (20072009) hospitalization rates were calculated.
Results. During 20072009, IDs accounted for 20% of hospitalisations among AN people. The 20072009
average annual age-adjusted ID hospitalisation rate (2126/100,000 persons) was higher than that for the
general US population (1679/100,000; 95% CI 16391720). The ID hospitalisation rate for AN people
increased from 2001 to 2009 (17%, pB0.001). Although the rate during 20012009 declined for AN infants
(B1 year of age; p0.03), they had the highest 20072009 average annual rate (15106/100,000), which was 3
times the rate for general US infants (5215/100,000; 95% CI 47835647). The annual rates for the age groups
14, 519, 4049, 5059 and 7079 years increased (pB0.05). The highest 20072009 age-adjusted average
annual ID hospitalisation rates were in the Yukon-Kuskokwim (YK) (3492/100,000) and Kotzebue (3433/
100,000) regions; infant rates were 30422/100,000 and 26698/100,000 in these regions, respectively. During
20072009, lower respiratory tract infections accounted for 39% of all ID hospitalisations and approximately
50% of ID hospitalisations in YK, Kotzebue and Norton Sound, and 74% of infant ID hospitalisations.
Conclusions. The ID hospitalisation rate increased for AN people overall. The rate for AN people remained
higher than that for the general US population, particularly in infants and in the YK and Kotzebue regions.
Prevention measures to reduce ID morbidity among AN people should be increased in high-risk regions and
for diseases with high hospitalisation rates.
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I
nfectious diseases (IDs) have caused excessive mor-
bidity and mortality among the American Indian and
Alaska Native (AI/AN) population in the United
States (14). Both hospitalisations and outpatient visits
due to IDs have been disproportionately higher in the
AI/AN population using the Indian Health Service
(IHS) healthcare system when compared to the general
US population (2,58). These disparities affected AI/AN
people of all ages, especially infants (B1 year of age) and
older adults (3,4,79). Studies of specific IDs, including
lower respiratory tract infections (LRTIs), diarrhoea-
related infections, and skin and ear infections, have
shown a disparity between AI/ANs and the general US
population (57,1013).
A high rate of ID hospitalisations has been reported in
the AI/AN population in Alaska (24,68,10), and the
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regionhasbeenreportedhigherthanthatforallotherIHS
regions and the general US population (2,3). Respiratory
disease has been implicated as a major health problem in
the AN population, especially among young children
(10,1217). The age-adjusted LRTI hospitalisation rate
for AN people was higher than that for the general US
population during 19982006 (2). Furthermore, a greater
disparity was seen among young children living in the
Yukon-Kuskokwim (YK) region, where the rate of
respiratory disease was much higher than that in other
regions of Alaska (13). The lack of in-home water service
inAlaska hasbeenidentified asonepotential causeforthe
higher respiratory and skin infection rates (1416).
The present study examines the epidemiology of ID
hospitalisations among AN people using IHS/tribal
health care system in Alaska, unlike most earlier studies
that consider the AI/AN population within the IHS/tribal
health care system in the United States. Rates of ID and
specific ID group hospitalisations for AN people are
analysed overall and for the regions in Alaska, along with
rates for the general US population for comparison.
Methods
Thisstudywasconductedusinghospitaldischargerecords
for AI/ANs living in Alaska. Approximately 140,000 AN
people are descendants of the indigenous population and
represent about 20% of the Alaska population (18). The
IHSfederal healthcareservices inAlaska areadministered
by regional AN-managed tribal health organisations
with some statewide facilities and services shared and
co-administered, such as the referral medical centre in
Anchorage(19).HospitaldischargerecordsforANpeople
were accessed from the IHS direct and contract health
service inpatient dataset, IHS National Patient Informa-
tion Reporting System (NPIRS), for 20012009. The IHS
inpatient data consist of all hospital discharge records
reported directly from IHS- or tribally-operated hospitals
and community hospitals, which are contracted with IHS
or tribes to provide healthcare services to eligible AI/AN
persons (1).
Hospitalisation records for the overall general US
population (all race groups) from the Nationwide In-
patient Sample (NIS) for 20012009 were analysed for
comparison with the IHS/tribal AN population of the
same time period (20). The NIS is a nationally represen-
tative survey of US short-term non-federal community
hospitals conducted by the Healthcare Cost and Utiliza-
tion Project in collaboration with participating states; the
data and the weighting methodology for the NIS are
described previously (20,21). Hospital stays for births
were excluded. The unit of analysis for the study was a
hospitalisation.
The ID hospitalisations were defined by using a
previously described ID classification method (2,21),
based on the International Classification of Diseases, 9th
revision, Clinical Modification (ICD-9-CM) codes (22).
First-listed ID hospitalisations were categorised into ID
groups as follows: tuberculosis (010018, 137); meningitis
(027.0, 036, 320.0321.3, 321.8); septicaemia (038, 449,
771.81, 995.90995.94); HIV/AIDS (042044, 279.1);
hepatobiliary disease (070, 095.3, 573.1, 573.2, 576.1);
mycoses (110118); infections of the heart (093, 391,
392.0, 393, 394.1, 395.0395.2, 397.1, 397.9, 398, 421,
422.0, 424.9); upper respiratory tract infections (032.0
032.3, 034.0, 098.6, 101, 460465, 473.0474.0, 475);
LRTIs (022.1, 031.0, 033, 095.1, 466, 480488, 510,
511.1, 513, 517.1, 770.0); abdominal and rectal infections
(095.2, 098.7, 540542, 566, 567.0567.2, 567.38, 569.5);
kidney, urinary tract and bladder infections (KUTBs)
(095.4, 099.4, 590, 595.0, 597, 598.0, 599.0); skin and soft
tissue infections (SSTIs) (680686); enteric infections
(001009, 022.2); viral central nervous system infections
(045049, 059.00, 059.09059.12, 059.19); infection due
to internal prosthetic device, implant and graft (996.6,
999.31); post-operative infection (780.62, 998.5); osteo-
myelitis, periostitis and other infections involving bone
(730); inflammatory disease of female pelvic organs
(614.0614.5, 616.0616.1, 616.3616.4, 625.71); and
infections related to pregnancy, childbirth, or puerperium
(634.0, 635.0, 636.0, 637.0, 638.0, 639.0, 646.5, 646.6, 647,
655.3, 658.4, 659.3, 670, 675) (2,21). First-listed ID
hospital discharge records were selected and examined
overall, by age, sex, Alaska IHS service area (region) and
specific ID group. Alaska regions were defined as follows:
Anchorage, Barrow, YK, Bristol Bay, Kotzebue, Mt.
Edgecumbe, Interior Alaska, Annette Island and Norton
Sound (23). All regions are included in the overall
analysis, while not all analyses are provided for each
region due to non-reporting and small numbers.
Annual and average-annual hospitalisation rates were
calculated as the number of hospitalisations per 100,000
corresponding population. Rates were calculated for first-
listed ID hospitalisations and ID groups. Analyses were
restricted to records in which the first-listed diagnosis was
an ID diagnosis, unless otherwise specified. To analyse
the most recent time period, average annual ID hospita-
lisation rates were calculated and analyses were presented
for 20072009. In addition, rate trends were analysed
for 20012009. The IHS Alaska user population for the
fiscal years 20012009 was used as the denominator for
corresponding populations (1). The user population
includes all people who received IHS-funded healthcare
service at least once during the previous 3 years (1,24).
Age-adjusted hospitalisation rates for both the IHS
Alaska population and the general US population were
calculated using the direct method, with the 2000
projected US population as the standard, (25) to adjust
for differences in the age distribution of popula-
tions. Trends in the annual hospitalisation rate during
Robert C. Holman et al.
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Month of hospital admission and length of stay (LOS)
were examined overall and by region. Median and
interquartile range (IQR) for age and LOS are presented.
Comparisons of age distribution between groups were
made using a Wilcoxon rank-sum test (27). Categorical
data were analysed using the Chi-square test. Statistical
tests were conducted using pB0.05 as the significance
level.
For the general US population, hospitalisation rates
with 95% confidence intervals (CIs) were calculated as
the weighted number of hospitalisations with population
denominators determined from the National Center for
Health Statistics bridged-race population estimates
(20,28). All calculations take into account the sampling
design of the NIS; hospitalisation and proportional
estimates and corresponding standard errors (SEs) were
calculated using SUDAAN software (29). To test for a
linear trend in the annual hospitalisation rate for the
general US population during 20012009, a weighted
least squares technique that accounts for the NIS sample
design was used (30).
Results
Trends in infectious disease hospitalisations,
20012009
The annual ID hospitalisation rate for AN people
increased during 20012009 (17% from 2001 to 2009;
pB0.001);therateforthegeneralUSpopulationsimilarly
increased(18%,95%CI1225%;pB0.001)(Fig.1A).The
ID hospitalisation rate for both AN males (14%,
p0.004) and AN females (20%, p0.002) increased.
Infants were the only age group to have a declining rate
(15%, p0.03); the age groups 14 (22%), 519 (31%),
4049 (30%), 5059 (16%) and 7079 (27%) years each
Fig. 1. A) Annual rates of ﬁrst-listed infectious disease (ID) hospitalisations among Alaska Native people, Alaska, and for the general
US population, 20012009 and B) Annual proportions of ﬁrst-listed and of any-listed ID hospitalisations in all hospitalisations among
Alaska Native people, Alaska, 20012009. *First-listed ID hospitalisations are hospitalisations where the ﬁrst diagnosis is an ID, any-
listed ID hospitalisations are hospitalisations with an ID ICD-9-CM code listed anywhere on the discharge record. Rate per 100,000
persons of corresponding group. Rates for Alaska Native people were determined from the Indian Health Service (IHS) direct and
contract health service inpatient dataset. Rates for the general US population used the Nationwide Inpatient Sample (NIS) to represent
all of the US population.
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generalUSinfantpopulationalsodecreased(22%,95%CI
637%, pB0.01). A significant rate increase was seen in
the following regions, Kotzebue (67%; pB0.001), Mt.
Edgecumbe (42%; p0.01) and Norton Sound (169%;
p0.003). The rate for YK remained high and did not
significantly change over time. For the ID groups among
AN people, significant rate increases were seen for LRTI
(16%; p0.04) and septicaemia (172%; pB0.001); a rate
change was not seen in the other ID groupswith sufficient
numbers. For the general US population, the rate for
LRTI decreased (7%, 95% CI 112%, pB0.01) and the
septicaemia rate increased (134%, 95% CI 117152%,
pB0.001).
Infectious diseases hospitalisations, 20072009
Infectious diseases accounted for 20% of all hospi-
talisations among AN people during 20072009; the
proportion for the general US population was 14.5%
(95% CI 14.314.7%). The annual proportion of ID
hospitalisations among all hospitalisations was relatively
stable throughout 20012009 (Fig. 1B); the proportion
among all general US hospitalisations was also stable.
The proportion of all ID hospitalisations ranged from
11% to 25% among Alaska regions. By age group for
AN people, the proportion of ID hospitalisations among
all hospitalisations for 20072009 was highest among
young children (51% in infants and 57% in 14 year
olds).
For 20072009, the median age for ID hospitalisations
for AN people was 28 years (IQR 2, 54 years). Thirty-
nine percent of the ID hospitalisations occurred in those
B20 years of age. The highest regional median age was in
Mt. Edgecumbe (46 years; IQR 22, 66) and lowest
median age was in YK (13 years; IQR 0, 47). The overall
and regional median ages for AN people were younger
than the median age of ID hospitalisations for the general
US population (57.9 years, 95% CI 57.159.4; IQR 34.2,
76.4).
Infectious disease hospitalisation rates, 20072009
The 20072009 average annual age-adjusted ID hospita-
lisation rate (2125.7/100,000) was higher for AN people
than for the general US population (1628/100,000, 95%
CI 16101646; Table I). The overall age-adjusted rates for
AN males and AN females were similar. The ID
hospitalisation rate was highest for AN infants, followed
by AN people ]80 years of age. The rate for AN infants
(15106.2/100,000) was much higher than the rate for the
general US infant population (5215/100,000, 95% CI
47835647; Table I). Both AN males and females had a
higher age-adjusted rate than those in the general US
Table I. Infectious disease hospitalisation rates among Alaska Native people by sex, age group and select regions, Alaska (IHS), and for
the general US population (NIS), 20072009
a
Characteristic Anchorage Barrow
Yukon-
Kuskokwim
Bristol
Bay Kotzebue
Mt.
Edgecumbe
Norton
Sound
Alaska Native
people overall US overall rate (95% CI)
Age-adjusted rates
Total 1691.0 2712.8 3491.5 1806.9 3433.1 2189.1 2298.7 2125.7 1628.0 (1609.61646.3)
Sex
Male 1635.0 2758.6 3636.6 1915.1 2649.1 2239.9 2106.0 2109.2 1643.3 (1623.61662.9)
Female 1733.7 2710.6 3360.2 1662.2 4221.4 2158.8 2497.5 2139.9 1616.6 (1598.81634.4)
Age group (years): age-specific rates
B1 5574.7 17061.6 30422.0 11878.5 26697.5 10173.2 20057.7 15106.2 5215.0 (4783.45646.6)
14 1187.5 3554.0 5451.5 1175.6 3991.6 1642.5 3362.0 2480.5 1247.9 (1150.31345.5)
519 561.6 1085.2 1251.8 627.2 1104.7 653.3 782.7 726.9 523.7 (491.9555.5)
2029 867.1 1611.4 2071.2 761.7 1734.8 1566.8 1039.8 1127.2 779.1 (754.0804.2)
3039 995.4 945.0 2252.9 782.4 1925.0 1304.7 1703.9 1216.3 909.8 (879.5940.0)
4049 1826.3 1940.0 2303.8 1478.1 2402.0 1558.9 1651.0 1727.2 1161.4 (1125.81197.0)
5059 2027.2 2938.8 2180.4 1536.6 2923.6 1921.9 2667.9 1936.2 1618.6 (1574.71662.5)
6069 2884.5 3260.9 4415.5 3082.2 3121.4 3953.8 3132.7 3035.7 2529.1 (2467.32590.9)
7079 3958.2 6925.2 9316.2 6060.6 10895.5 6551.2 4918.0 5525.6 4720.0 (4604.34835.8)
]80 6336.9 12562.8 12488.4 7279.7 15596.3 8529.7 6045.3 7838.7 9348.0 (9093.69602.4)
aRate per 100,000 persons of corresponding group. Rates for Alaska Native people were determined from the Indian Health Service (IHS)
direct and contract health service inpatient dataset. Rates for the general US population used the Nationwide Inpatient Sample (NIS) to
represent all of the US population. The 20072009 average annual regional populations for the Alaska Native people were as follows:
Anchorage (57082), Barrow (4358), Yukon-Kuskokwim (24707), Bristol Bay (5277), Kotzebue (7038), Mt. Edgecumbe (15073), Norton
Sound (8281), Interior Alaska (12959) and Annette Island (1415). Specific Interior Alaska and Annette Island regions are included in the
overall analysis, but not presented individually due to non-reporting and small numbers.
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rate was highest for YK, followed by Kotzebue and
Barrow (Table I). The AN infant rate was highest in YK
and Kotzebue. In all regions, the overall age-adjusted ID
hospitalisation rates were greater than the rate for the
general US population. The age-specific ID hospitalisa-
tion rates for AN males and AN females were similar for
each age group, except for AN infants where the rate for
males was higher than for females (16568 and 13528/
100,000, respectively) and for the 2029 year age group
where the rate for females was higher than the rate for
males (1342 and 906/100,000, respectively).
Hospital month of admission and length of stay,
20072009
The proportion of ID admissions by month for AN
people did not vary substantially overall (79%) or within
each region. The median LOS for ID hospitalisations was
3 days (IQR 2, 6 days) and was similar for males and
females. The median LOS ranged from 3 to 4 days for
most regions.
Overall, 16% of hospital admissions were for B2d a y s .
This proportion varied by region, Anchorage (14%),
Barrow (20%), YK (13%), Bristol Bay (17%), Kotzebue
(20%), Mt. Edgecumbe (24%) and Norton Sound (17%);
the Anchorage and YK regions had a higher proportion
of hospitalisations ]2 days than each of the other
regions (pB0.05). The proportion for the general US
population was 13% (SE0.1%).
Infectious disease groups and diagnoses, 20072009
LRTI was the primary diagnosis on 39% of the ID
hospitalisations among AN people. The proportion of ID
hospitalisations that were due to LRTI was high in
Norton Sound (56%), YK (47%), Kotzebue (47%) and
Barrow (44%) compared to the general US population
(27.5%, 95% CI 27.127.9%). The proportion for the
Anchorage area (27%) was similar to the general US
population. The LRTI hospitalisations among AN peo-
ple were primarily (61%) listed as ‘‘pneumonia, organism
unspecified.’’
The highest average annual hospitalisation rate among
all ID groups among AN people was for LRTI (Table II).
The overall average annual age-adjusted LRTI rate for
AN people was almost twice that of the general US
population; all Alaska regions with the exception of two
exceeded the general US population rate. The regional
age-adjusted LRTI hospitalisation rates were highest
for AN people in YK, Kotzebue and Norton Sound
(Table III). The LRTI rate was highest for AN infants
(11190/100,000) compared to other AN age groups and
to the general US infant population rate (3018/100,000;
95% CI 27793258). The infant LRTI rate was highest
in YK (22718/100,000) followed by Kotzebue (19444/
100,000) and Norton Sound (17172/100,000).
The second most common ID group among AN
people was SSTIs (Tables II and III), with a higher
proportion of the ID hospitalisations (16%) than that for
the general US population (12.1%; 95% CI 11.912.3%).
The proportion of ID hospitalisations that were due to
Table II. Age-adjusted hospitalisation rates for select infectious disease groups among Alaska Native people in Alaska and for the
overall general US population, 20072009
a
Alaska Native people United States
Infectious disease group Age-adjusted rate Age-adjusted rate (95% CI)
Lower respiratory tract infection 812.9 445.3 (439.4451.2)
Skin and soft tissue infections 354.0 198.3 (195.7200.8)
Abdominal and rectal infection 148.7 117.2 (114.9119.5)
Kidney, urinary tract and bladder infection 190.2 174.5 (172.0177.0)
Septicaemia 163.1 232.0 (228.2235.8)
Upper respiratory tract infection 58.3 33.1 (32.234.0)
Infection related to pregnancy, childbirth, or puerperium
b 117.3 71.6 (69.573.8)
Postoperative infection 51.1 50.3 (49.551.2)
Enteric infection 40.1 74.9 (73.676.2)
Infection due to internal prosthetic device, implant, or graft 32.1 70.7 (69.571.9)
Osteomyelitis, periostitis and other infections involving bone 20.7 18.4 (18.018.8)
Infections of the heart 22.5 14.3 (13.914.8)
Viral central nervous system infection 10.8 11.0 (10.611.3)
aRate per 100,000 persons of corresponding group. Infectious disease groups with at least 50 hospitalisations were displayed. Rates for
Alaska Native people were determined from the Indian Health Service (IHS) direct and contract health service inpatient dataset. Rates for
the general US population used the Nationwide Inpatient Sample (NIS) to represent all of the US population.
bFemale only.
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adjusted rate for males was higher than that for females
in almost all regions. The regional age-adjusted SSTI
rate for AN people was highest in YK, followed by
Barrow and Kotzebue regions (Table III). Kidney urinary
tract and bladder infections accounted for 7% of the
ID hospitalisations and accounted for a lower propor-
tion of IDs than for the general US population (10.8%;
95% CI 10.611%). The KUTB infection rate for
females was higher than that for males. The age-adjusted
KUTB rate was highest in Kotzebue followed by YK
(Table III).
Discussion
In the present evaluation of ID hospitalisation records,
the rate increased during 20012009 for both the AN
people and the general US population. This increase
among AN people was seen among both males and
females. The ID hospitalisation rate increased during
20012009 in some age groups, but decreased for AN
infants even though AN infants had the highest rate
among all age groups. The rate also decreased for the
general US infant population. Four of the Alaska regions
showed an ID hospitalisation rate increase. The rate for
YK region, which had the highest ID hospitalisation rate,
remained unchanged during the study period. The 2007
2009 age-adjusted ID hospitalisation rate for AN people
was higher than that for the general US population.
Regionally, the ID hospitalisation rate was highest for
the YK region, followed by the Kotzebue and Barrow
regions.
The on-going ID disparities among AN people,
especially in rural regions and among infants, may be
attributed to household crowding, household air pollu-
tion, lack of in-home water service and consequences of
poverty (1416,31,32). Despite considerable progress,
approximately 18% of rural AN homes still lack in-
home water and sanitation services (personal commu-
nication, Matt Dixon, AN Tribal Health Consortium,
January 19, 2012). Lack of access to in-home water
service, which leads to water rationing and reduced access
to water for hand and body hygiene, has been associated
Table III. Hospitalisation rates for select infectious disease groups among Alaska Native people by region, Alaska, 20072009
a
Anchorage Barrow
Yukon-
Kuskokwim Bristol Bay
Infectious disease group No. Rate No. Rate No. Rate No. Rate
Lower respiratory tract infection 637 472.6 154 1094.3 1197 1513.0 107 744.8
Skin and soft tissue infections 389 266.5 53 461.8 520 806.7 39 302.2
Abdominal and rectal infection 240 125.5 33 217.1 182 227.9 27 149.6
Kidney, urinary tract and bladder infection 192 186.7 22 225.2 146 283.9 19 153.3
Septicaemia 239 222.8 18 166.0 76 137.9 14 113.1
Upper respiratory tract infection 52 25.1 15 77.6 69 65.3 * *
Infection related to pregnancy, childbirth, or
puerperium
b
132 116.2 14 223.6 64 162.8 * *
Kotzebue Mt. Edgecumbe Norton Sound Overall Alaska
Infectious disease group No. Rate No. Rate No. Rate No. Rate
Lower respiratory tract infection 330 1460.7 277 761.2 321 1245.4 3029 812.9
Skin and soft tissue infections 74 433.0 127 309.6 58 266.9 1268 354.0
Abdominal and rectal infection 45 213.9 73 168.4 40 144.8 645 148.7
Kidney, urinary tract and bladder infection 61 442.6 80 200.0 21 86.1 546 190.2
Septicaemia 20 124.6 57 158.8 20 92.2 465 163.1
Upper respiratory tract infection 33 116.2 83 172.0 25 73.3 286 58.3
Infection related to pregnancy, childbirth, or
puerperium
b
32 301.6 16 55.2 20 67.8 285 117.2
aRate per 100,000 persons of corresponding group. Rates for Alaska Native people were determined from the Indian Health Service (IHS)
direct and contract health service inpatient dataset. The Interior Alaska and Annette Island regions are included in the overall analysis, but
not presented due to non-reporting and small number of hospitalisations.
bFemale only.
*Less than 10 hospitalisations.
Robert C. Holman et al.
6
(page number not for citation purpose)
Citation: Int J Circumpolar Health 2013, 72: 20994 - http://dx.doi.org/10.3402/ijch.v72i0.20994with increased respiratory disease rates among AN
children (1416,31).
Among the age groups, AN infants showed the greatest
ID disparity compared to the general US infant popula-
tion, with rates nearly 3-fold higher. Encouragingly, the
hospitalisation rate decreased by 15% during 20012009
for AN infants. However, AN infants have the highest ID
hospitalisation rate of all age groups. The most common
cause of AN infant hospitalisations is LRTIs, and rates in
Alaska have been higher than rates for AI/ANs from
other IHS regions (7,10,13).
The age-adjusted average annual LRTI hospitalisation
rate for AN people was the highest among ID groups and
was almost 2-fold higher than the rate for the general US
population. Earlier studies of AI/ANs have found higher
hospitalisation rates for LRTI and bronchiolitis in Alaska
compared to the general US population, (10,12,13)
including an increase in pneumonia hospitalisations
among older AN adults (9). The LRTI hospitalisation
rates varied considerably among Alaska regions; reasons
for this are not clear. However, LRTI was still the most
common cause of hospitalisation for each region. High
rates of respiratory infections have been previously
reported among children for the YK region (13,14,33).
The present study has some limitations. Hospital
diagnoses may be incomplete or inaccurate due to use
of ICD-9-CM coding to identify ID hospitalisations, and
diagnostic coding may vary by practice. The first-listed
diagnosis was used to identify ID hospitalisations in an
attempt to limit misclassification of non-ID hospitalisa-
tions. However, this conservative method means that any
true ID hospitalisations in which an ID was not the first-
listed diagnosis were not included. The unit of analysis
was a hospitalisation, therefore any multiple hospitalisa-
tions and/or hospital transfers for a patient’s event were
included. Certain ID groups may be better expressed by
using a different denominator for their rate calculation
such as analysing infection related to pregnancy, child-
birth or puerperium with pregnancies as the denominator
or post-operative infections with number of procedures as
the denominator; however, this was not possible in the
present study as data was not available.
The denominator for the AN population in the present
study is based on the number of AI/ANs who utilise the
tribal healthcare system in Alaska and may not include
all Alaska Native people who are eligible for healthcare
at tribal facilities which would underestimate the denomi-
nator. However, some additional limitations that we
are aware of indicate that our reported rates of hospita-
lisations for AN people may be an underestimate. AN
patients who are eligible for healthcare within the tribal
healthcare system may receive care outside the system;
therefore, their hospitalisations would not be included in
the present study. Also, reporting of hospitalisations for
Alaska regions to IHS National Patient Information
Reporting System, as well as reporting for the NIS, may
not be complete. In an earlier investigation, 8 influenza
hospitalisations were found in the Interior Alaska region
in September and October of 2009 (34), while there were
none reported to NPIRS for that period. The reasons for
and the extent of the under-reporting are not known and
deserve further investigation. The denominator used to
estimate rates for AN people in the present study was
estimated as the number of AN people who used the IHS/
tribal healthcare system, whereas the US census data
were used as the denominator to estimate the rates for the
general US population, which may have affected the
comparability of the rates for the two populations.
However, the difference between the IHS user population
and the corresponding census data has been reported to
be small (24). Further study of IDs using Alaska hospital
discharge data, along with IHS/tribal inpatient data,
would allow for additional examination of disparities and
other characteristics of ID hospitalisation within Alaska.
Conclusion
The rate of ID hospitalisations increased for AN people
during 20012009 and ID hospitalisation rates in all
Alaska regions remain higher than the general US
population. The rate disparity is substantially greater in
the YK and Kotzebue regions, although in-home water
and sanitation service progress is being made in rural
Alaska. The disparity in hospitalisation rates is greatest
for AN infants, primarily due to LRTIs. It is important to
increase efforts and to implement strategies to prevent or
reduce the ID health disparities through public health
interventions and education to improve the health status
of AN people, as well as continued improvements in areas
such as access to in-home water. The strategies should
focus on age groups and regions at high risk of ID
hospitalisation, along with illnesses contributing most to
the substantial health disparity.
Acknowledgements
We thank Donald Reece and Barbara Strzelczyk (IHS) for
technical assistance and also the staff at the participating hospitals
and the IHS National Patient Information Reporting System.
Disclosure
The findings and conclusions in this article are those of the
authors and do not necessarily represent the official position
of the funding agencies.
Conflict of interest and funding
The authors have not received any funding or benefits from
industry or elsewhere to conduct this study.
Infectious disease hospitalisations in Alaska Native people
Citation: Int J Circumpolar Health 2013, 72: 20994 - http://dx.doi.org/10.3402/ijch.v72i0.20994 7
(page number not for citation purpose)References
1. Indian Health Service. Trends in Indian Health, 20022003
Edition. Rockville, MD: Indian Health Service; 2009.
2. Holman RC, Folkema AM, Singleton RJ, Redd JT,
Christensen KY, Steiner CA, et al. Disparities in infectious
disease hospitalizations for American Indian/Alaska Native
people. Public Health Rep. 2011;126:50821.
3. Holman RC, Curns AT, Cheek JE, Singleton RJ, Anderson LJ,
Pinner RW. Infectious disease hospitalizations among
American Indian and Alaska Native infants. Pediatrics.
2003;111:E17682.
4. Holman RC, Curns AT, Singleton RJ, Sejvar JJ, Butler JC,
Paisano EL, et al. Infectious disease hospitalizations among
older American Indian and Alaska Native adults. Public
Health Rep. 2006;121:67483.
5. Singleton RJ, Holman RC, Yorita KL, Holve S, Paisano EL,
Steiner CA, et al. Diarrhea-associated hospitalizations and
outpatient visits among American Indian and Alaska Native
children younger than ﬁve years of age, 20002004. Pediatr
Infect Dis J. 2007;26:100613.
6. Singleton RJ, Holman RC, Plant R, Yorita KL, Holve S,
Paisano EL, et al. Trends in otitis media and myringtomy with
tube placement among American Indian/Alaska Native chil-
dren and the US general population of children. Pediatr Infect
Dis J. 2009;28:1027.
7. Holman RC, Curns AT, Cheek JE, Bresee JS, Singleton RJ,
Carver K, et al. Respiratory syncytial virus hospitalizations
among American Indian and Alaska Native infants and
the general United States infant population. Pediatrics.
2004;114:e43744.
8. Murphy TV, Syed SB, Holman RC, Haberling DL,
Singleton RJ, Steiner CA, et al. Pertussis-associated hospita-
lizations in American Indian and Alaska Native infants. J
pediatr. 2008;152:83943.
9. Holman RC, Yorita KL, Singleton RJ, Sejvar JJ, Butler JC,
Paisano EL, et al. Increasing rate of pneumonia hospitaliza-
tions among older American Indian and Alaska Native adults.
J Health Dispar Res Pract. 2007;2:3548.
10. Peck AJ, Holman RC, Curns AT, Lingappa JR, Cheek JE,
Singleton RJ, et al. Lower respiratory tract infections among
American Indian and Alaska Native children and the
general population of U.S. Children. Pediatr Infect Dis J.
2005;24:34251.
11. Reynolds MG, Holman RC, Yorita Christensen KL, Cheek JE,
Damon IK. The incidence of molluscum contagiosum among
American Indians and Alaska Natives. PLoS One. 2009;
4:e5255.
12. Lowther SA, Shay DK, Holman RC, Clarke MJ, Kaufman SF,
Anderson LJ. Bronchiolitis-associated hospitalizations among
American Indian and Alaska Native children. Pediatr Infect
Dis J. 2000;19:117.
13. Singleton RJ, Holman RC, Folkema AM, Wenger JD, Steiner
CA, Redd JT. Trends in lower respiratory tract infection
hospitalizations among American Indian/Alaska Native
children and the general US child population. J pediatr.
2012;161:292302 e292.
14. Wenger JD, Zulz T, Bruden D, Singleton R, Bruce MG,
Bulkow L, et al. Invasive pneumococcal disease in Alaskan
children: impact of the seven-valent pneumococcal conjugate
vaccine and the role of water supply. Pediatr Infect Dis J.
2010;29:2516.
15. Gessner BD. Lack of piped water and sewage services is
associated with pediatric lower respiratory tract infection in
Alaska. J pediatr. 2008;152:66670.
16. Hennessy TW, Ritter T, Holman RC, Bruden DL, Yorita KL,
Bulkow L, et al. The relationship between in-home water
service and the risk of respiratory tract, skin, and gastro-
intestinal tract infections among rural Alaska Natives. Am J
Public Health. 2008;98:20728.
17. Singleton RJ, Holman RC, Wenger J, Christensen KY, Bulkow
LR, Zulz T, et al. Trends in hospitalization for empyema in
Alaska Native children younger than 10 years of age. Pediatr
Infect Dis J. 2011;30:52830.
18. State of Alaska, US Census 2010 data. [cited 2012 Oct 9].
Available from: http://live.laborstats.alaska.gov/cen/dp.cfm
19. Alaska Area. [cited 2012 Oct 9]. Available from: http://www.
ihs.gov/alaska/
20. HCUP NIS Database Documentation. Healthcare Cost and
Utilization Project (HCUP). Agency for Healthcare Research
and Quality. [cited 2011 Nov 1]. Available from: http://www.
hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp.
21. Christensen KL, Holman RC, Steiner CA, Sejvar JJ, Stoll BJ,
Schonberger LB. Infectious disease hospitalizations in the
United States. Clin Infect Dis. 2009;49:102535.
22. International Classiﬁcation of Diseases, Ninth Revision,
Clinical Modiﬁcation (ICD-9-CM); 2011. Available from:
http://www.cdc.gov/nchs/icd/icd9cm.htm
23. Alaska Area. [cited 2012 Apr 11]. Available from: http://www.
ihs.gov/alaska/documents/hf/area.pdf
24. Rhoades ER. American Indian health: innovations in health
care, promotion, and policy. Baltimore, MD: Johns Hopkins
University Press; 2000.
25. Klein RJ, Schoenborn CA. Age adjustment using the projected
US population. Healthy People Statistical Notes, no. 20.
Hyattsville, MD: National Center for Health Statistics; 2001.
26. Kleinbaum D, Kupper L, Muller K, Nizam A. Applied
regression analysis and multivariable methods, 3rd ed. Paciﬁc
Grove, CA: Duxbury Press; 1998.
27. Lehmann E. Nonparametrics: statistical methods based on
ranks. New York, NY: Wiley; 1975.
28. United States Department of Health and Human Services (US
DHHS), Centers for Disease Control and Prevention (CDC),
National Center for Health Statistics (NCHS). Bridged-race
population estimates, United States July 1st resident popula-
tion by state, county, age, sex, bridged-race, and Hispanic
origin, compiled from 19901999 bridged-race intercensal
population estimates and 20002009 (Vintage 2009) bridged-
race postcensal population estimates, on CDC WONDER
On-line Database. [cited 2011 Jul 11]. Available from http://
wonder.cdc.gov/bridged-race-v2009.html.
29. Research Triangle Institute. SUDAAN user’s manual, release
10.0. Research Triangle Park, NC: Research Triangle Institute;
2008.
30. Houchens R, Elixhauser A. Final Report on Calculating
Nationwide Inpatient Sample (NIS) Variances, 2001. HCUP
Method Series Report # 200302. ONLINE June 2005
(revised June 6, 2005). U.S. Agency for Healthcare Research
and Quality. Available from: http://www.hcup-us.ahrq.gov/
reports/CalculatingNISVariances200106092005.pdf. 2005.
31. Bulkow LR, Singleton RJ, Karron RA, Harrison LH. Risk
factors for severe respiratory syncytial virus infection among
Alaska native children. Pediatrics. 2002;109:2106.
32. Colosia AD, Masaquel A, Hall CB, Barrett AM, Mahadevia
PJ, Yogev R. Residential crowding and severe respiratory
Robert C. Holman et al.
8
(page number not for citation purpose)
Citation: Int J Circumpolar Health 2013, 72: 20994 - http://dx.doi.org/10.3402/ijch.v72i0.20994syncytial virus disease among infants and young children: a
systematic literature review. BMC Infect Dis. 2012;12:95.
33. Karron RA, Singleton RJ, Bulkow L, Parkinson A, Kruse D,
DeSmet I, et al. Severe respiratory syncytial virus disease in
Alaska Native children. RSV Alaska Study Group. J Infect
Dis. 1999;180:419.
34. Wenger JD, Castrodale LJ, Bruden DL, Keck JW, Zulz T,
Bruce MG, et al. Pandemic inﬂuenza A H1N1 in Alaska:
temporal and geographic characteristics of spread and in-
creased risk of hospitalization among Alaska Native and
Asian/Paciﬁc Islander people. Clin Infect Dis. 2011;52
(Suppl 1):S18997.
*Robert C. Holman
Division of High-Consequence Pathogens and Pathology
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Mailstop A-30, Atlanta, GA 30333
USA
Email: RHolman@cdc.gov
Infectious disease hospitalisations in Alaska Native people
Citation: Int J Circumpolar Health 2013, 72: 20994 - http://dx.doi.org/10.3402/ijch.v72i0.20994 9
(page number not for citation purpose)